Markets

News Details

( 31 Oct 2020)
Sun Pharma. - Press Release

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 31, 2020, titled "Press Release Sun Pharma Announces 5-Year Sustained Efficacy and Safety Results for ILUMYA?? (tildrakizumab-asmn) in Patients with Moderate-to-Severe Plaque Psoriasis".